Charles Cherington Brooklyn Immuno Therapeutics, Inc. (BTX) insider trading activity

Charles Cherington is > 10% Shareholder of Brooklyn ImmunoTherapeutics, Inc.. Currently has a direct ownership of 41.7 Million shares of BTX, which is worth approximately $0. The most recent transaction as insider was on Jun 09, 2025, when has been sold 21,241,163 shares (Common Stock) at a price of $0.1 per share, resulting in proceeds of $2,124,116. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.7M

104.2% 3M change

7386.5% 12M change

Total Value Held $0

Charles Cherington Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2025	BUY Open market or private purchase	$2,124,116 $0.1 p/Share	21,241,163 Added 33.77%	41,659,743 Common Stock
Apr 02 2025	BUY Open market or private purchase	$376,839 $0.1 p/Share	3,768,397 Added 15.59%	20,401,602 Common Stock
Oct 29 2024	BUY Conversion of derivative security	$1,409,773 $0.5 p/Share	2,819,546 Added 14.5%	16,628,123 Common Stock
Oct 29 2024	BUY Open market or private purchase	-	13,252,112 Added 48.97%	13,808,577 Common Stock
Dec 02 2022	BUY Open market or private purchase	$858,559 $3.28 p/Share	261,756 Added 31.99%	556,465 Common Stock
Jun 17 2021	SELL Open market or private sale	$3,204,000 $16.02 p/Share	200,000 Reduced 3.28%	5,894,101 Common Stock
Jun 16 2021	SELL Open market or private sale	$3,146,000 $15.73 p/Share	200,000 Reduced 3.18%	6,094,101 Common Stock
Jun 01 2021	BUY Other acquisition or disposition	-	92 Added 0.0%	5,894,193 Common Stock

Also insider at

CMRA

Comera Life Sciences Holdings, Inc. Healthcare

> 10% Shareholder